Accessibility StatementSkip Navigation TULSA, Okla., Dec. 2, 2025 /PRNewswire/ -- ONE Gas, Inc. (NYSE: OGS) today announced its participation in several upcoming investor conferences in New York City. The company will attend the Mizuho Power, Energy & Infrastructure Conference on Monday, Dec. 8, 2025, the Jefferies Gas Utilities Virtual Mini- Conference on Tuesday, Dec. 9, 2025, and the Wells Fargo Midstream, Energy & Utilities Symposium on Wednesday, Dec. 10, 2025. Robert S. McAnnally, president and chief ...

Core Viewpoint - Tailwind 2.0 Acquisition Corp. will allow holders of its initial public offering units to separately trade Class A ordinary shares and rights starting December 8, 2025 [1][2]. Company Overview - The Company was established to pursue mergers, amalgamations, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with various businesses [3]. - The Company aims to focus on opportunities in industries related to energy and compute infrastructure, specifically targeting structural inefficiencies in energy routing, compute optimization, and grid intelligence [3]. Trading Information - The separated Ordinary Shares and Rights will trade on the Nasdaq Global Market under the symbols "TDWD" and "TDWDR," respectively, while the units that remain unseparated will continue to trade under the symbol "TDWDU" [2]. - Holders of Units must contact the Company's transfer agent, Lucky Lucko, Inc. d/b/a Efficiency, to separate the Units into Ordinary Shares and Rights [2]. Offering Details - The Units were initially offered through an underwritten offering, with Cohen & Company Capital Markets serving as the lead book-running manager [4]. - The registration statement for the Company's securities became effective on November 5, 2025 [5].

Subject to final state approval, the Dispensing Organization License grants Verano permission to cultivate, process and dispense medical cannabis across the state to support expansion of the Texas Compassionate Use Program CHICAGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (along with its subsidiaries, “Verano” or the “Company”), a leading multi-state cannabis company, today announced the Texas Department of Public Safety has awarded Verano a conditional Dispensi ...

Core Viewpoint - Vestand Incorporated has received a notice from Nasdaq regarding non-compliance with listing rules due to the failure to file its Quarterly Report on Form 10-Q for the period ended September 30, 2025 [1][2]. Group 1: Compliance and Regulatory Actions - The company has 60 calendar days to submit a plan to regain compliance with Nasdaq Listing Rule 5250(c)(1) [2]. - If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days, allowing compliance until May 18, 2026 [2]. - The notice does not have an immediate effect on the listing of the company's Class A Common Stock [2]. Group 2: Company Intentions and Future Steps - The company intends to take necessary steps to regain compliance with Nasdaq Listing Rules as soon as practicable [3]. - There is no assurance that the Form 10-Q will be filed within the required timeframe or that Nasdaq will grant an extension [3]. Group 3: Company Overview - Vestand is a U.S. Nasdaq-listed company that integrates traditional real-world assets with next-generation crypto treasury strategies [4]. - The company aims to connect global capital markets through its U.S. and Korean subsidiaries, focusing on a growth model that combines real estate, security technology, and blockchain innovation [4].

Core Insights - Red Cat Holdings, Inc. has announced two key leadership transitions aimed at enhancing operational execution and financial performance as the company accelerates growth [1][5] Leadership Changes - Christian Ericson has been promoted from Chief Financial Officer (CFO) to Chief Operating Officer (COO), where he will oversee daily operations, optimize supply chain and production processes, and drive strategic initiatives for efficiency and profitability [2][5] - Christian Morrison has been appointed as the new Chief Financial Officer (CFO), bringing over 20 years of experience in corporate finance, including significant milestones such as IPOs and M&A transactions [3][4] Executive Statements - CEO Jeff Thompson praised Ericson's financial leadership and industry expertise, emphasizing the importance of his role in meeting the growing demand for Red Cat's drone systems [3] - Morrison expressed enthusiasm about joining Red Cat during a transformative period in the drone industry and aims to drive financial discipline and strategic growth initiatives [4] Company Overview - Red Cat Holdings, Inc. specializes in advanced all-domain drone and robotic solutions for defense and national security, with subsidiaries like Teal Drones and FlightWave Aerospace [6] - The company is expanding its capabilities into maritime operations through Blue Ops, Inc., focusing on uncrewed surface vessels (USVs) to enhance safety and mission effectiveness [6]

Core Insights - Zymeworks Inc. is actively participating in significant upcoming conferences, including the ASCO Gastrointestinal Cancers Symposium and the J.P. Morgan Annual Healthcare Conference, showcasing its innovative biotherapeutics and clinical trials [1][5]. Conference Participation - Zymeworks will present a Trial-in-Progress poster for ZW251, a GPC3-targeting antibody-drug conjugate for hepatocellular carcinoma, at the ASCO GI Symposium on January 9, 2026 [2]. - The company will also highlight the late-breaking HERIZON-GEA-01 presentation, focusing on Ziihera® in HER2-driven gastrointestinal cancers, at the same symposium [1][3]. Presentation Details - The ZW251 presentation will be part of a multicenter study involving participants with hepatocellular carcinoma, scheduled for January 9, 2026, from 11:30 am to 1:00 pm PT [2]. - The HERIZON-GEA-01 study results will be presented on January 8, 2026, during the Oral Abstract Session A, focusing on advanced HER2-positive gastroesophageal adenocarcinoma [3]. Company Overview - Zymeworks is a biotechnology company focused on developing a diverse pipeline of multifunctional biotherapeutics aimed at improving treatment for difficult diseases, including cancer [6]. - The company utilizes its proprietary Azymetric™ technology to engineer Ziihera®, a HER2-targeted bispecific antibody, and has established partnerships for its commercialization [6].

SAN DIEGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- LPL Financial LLC today announced that Rich Steinmeier, Chief Executive Officer, will present at the Goldman Sachs Financial Services Conference on December 9. The presentation takes place at 8 a.m. ET. A live audio webcast of the presentation will be accessible at investor.lpl.com, with a replay available on the website after the presentation. Contacts Investor Relationsinvestor.relations@lplfinancial.com Media Relationsmedia.relations@lplfinancial.com About LPL ...

SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the Oppenheimer Movers in Rare Disease Summit being held on December 11, 2025, in New York, NY. Thane Wettig, Chief Executive Officer of FibroGen, will participate in a panel titled Elevator Pitches from Rare Disease Companies with Key Near-Term, Potentially Stock-Moving Catalysts on Thursday, December 11 at 12:15 PM ET at the Sofitel New York. FibroGen’s manage ...

Discover how to build resilient, prevention-first AI security — from models and agents to cloud workloads and connectivity. Live on December 4REDWOOD CITY, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Artificial intelligence is transforming the enterprise at unprecedented speed. AI now underpins critical workloads, cloud operations, identity systems, code pipelines, and everyday collaboration tools. As these systems expand across hybrid cloud and edge environments, organizations face a new challenge: how to se ...

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights11/30/2025 200,777,718 Total gross of voting rights: 200,777,718 Total net* of voting rights: 200,667,869 * Net total = total number of voting rights attached to shares – shares without votin ...